Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese <it>db/db</it> mice

<p>Abstract</p> <p>Background</p> <p>Telmisartan is a well-established angiotensin II type 1 receptor blocker that improves insulin sensitivity in animal models of obesity and insulin resistance, as well as in humans. Telmisartan has been reported to function as a parti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Shiota Asuka, Shimabukuro Michio, Fukuda Daiju, Soeki Takeshi, Sato Hiromi, Uematsu Etsuko, Hirata Yoichiro, Kurobe Hirotsugu, Maeda Norikazu, Sakaue Hiroshi, Masuzaki Hiroaki, Shimomura Iichiro, Sata Masataka
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2012-11-01
Colecção:Cardiovascular Diabetology
Assuntos:
Adiponectin
AMP-activated protein kinase
Obesity
Peroxisome proliferator-activated receptor-γ
SIRT1
Acesso em linha:http://www.cardiab.com/content/11/1/139
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados